http://localhost:1313/tags/%E7%B1%B3%E8%BE%BE%E7%BE%8E%E6%9B%BF%E5%B0%BC/ Recent content in 米达美替尼 on 神经纤维瘤资讯小屋 Hugo -- gohugo.io zh-cn Wed, 01 Apr 2026 10:00:00 +0800 http://localhost:1313/posts/mirdametinib-fda-approval/ Wed, 01 Apr 2026 10:00:00 +0800 http://localhost:1313/posts/mirdametinib-fda-approval/ FDA正式批准米达美替尼（Gomekli）用于治疗2岁及以上NF1相关症状性丛状神经纤维瘤患者，成为首款覆盖成人与儿童全人群的MEK抑制剂